Proto Script Pharmaceutical Corp.

PSCR

US74373V1052

Business Support Services

Market Closed - OTC Markets Other stock markets 11:02:13 2024-03-28 am EDT			5-day change	1st Jan Change
0.0002 ^USD	+19,900.00%		-.--%	-.--%

2017	Proto Script Pharmaceutical Enters Partnership with PAKmed	CI
2016	Proto Script Pharmaceutical Corp. will Change its Ticker to PSCR from YNXG.D	CI

Proto Script Pharmaceutical Corp. will Change its Ticker to PSCR from YNXG.D

November 09, 2016 at 12:00 am EST

Effective November 09, 2016, Proto Script Pharmaceutical Corp. will change its Pink Sheets LLC stock ticker symbol to PSCR from YNXG.D.

Latest news about Proto Script Pharmaceutical Corp.

Proto Script Pharmaceutical Enters Partnership with PAKmed	17-04-21	CI
Proto Script Pharmaceutical Corp. will Change its Ticker to PSCR from YNXG.D	16-11-09	CI
Proto Script Pharmaceutical Corp. Announces Management Changes	16-11-07	CI
Yanex Group, Inc. will Change its Ticker to YNXGD from YNXG	16-10-13	CI
Yanex Group, Inc. Announces Management Changes	16-09-09	CI
Yanex Group Seeks Acquisitions	16-09-09	CI
Yanex Group, Inc. Reports Unaudited Consolidated Earnings Results for the Three Months Ended March 31, 2016	16-07-05	CI
Proto-Script Pharmaceuticals, Corp. acquired Yanex Group, Inc. in a reverse merger transaction.	16-07-04	CI
Michelle Rico acquired Proto-Script Pharmaceuticals Corp. from other stockholders.	15-03-16	CI
Proto-Script Pharmaceuticals Corp. agreed to acquire 49.29% in Wolverine Holding Corp. from Coral Capital Partners, Inc. for $0.06 million.	15-01-23	CI

Chart Proto Script Pharmaceutical Corp.

Duration

Period

More charts

Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.

Sector

Business Support Services

More about the company

Sector Other Business Support Services

	1st Jan change	Capi.
PROTO SCRIPT PHARMACEUTICAL CORP.	-.--%	11.38K
CINTAS CORPORATION	+10.55%	67.6B
JACOBS SOLUTIONS INC.	+11.64%	18.21B
RB GLOBAL, INC.	+9.40%	13.37B
INTERTEK GROUP PLC	+16.53%	9.94B
TELEPERFORMANCE SE	-32.90%	5.74B
GENPACT LIMITED	-10.98%	5.57B
MAXIMUS, INC.	-4.09%	4.91B
EXLSERVICE HOLDINGS, INC.	-4.83%	4.87B
PLUXEE N.V.	0.00%	4.3B

Other Business Support Services